Cargando…

Immunotargeting of cancer stem cells

Cancer stem cells (CSCs) represent a distinctive population of tumour cells that control tumour initiation, progression, and maintenance. Their influence is great enough to risk the statement that successful therapeutic strategy must target CSCs in order to eradicate the disease. Because cancer stem...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kwiatkowska-Borowczyk, Eliza P., Gąbka-Buszek, Agnieszka, Jankowski, Jakub, Mackiewicz, Andrzej
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Termedia Publishing House 2015
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4322523/ https://www.ncbi.nlm.nih.gov/pubmed/25691822 http://dx.doi.org/10.5114/wo.2014.47129

Ejemplares similares

Novel Genetic Melanoma Vaccines Based on Induced Pluripotent Stem Cells or Melanosphere-Derived Stem-Like Cells Display High Efficacy in a murine Tumor Rejection Model
por: Gąbka-Buszek, Agnieszka, et al.
Publicado: (2020)

Whole cell melanoma vaccine genetically modified to stem cells like phenotype generates specific immune responses to ALDH1A1 and long-term survival in advanced melanoma patients
por: Kwiatkowska-Borowczyk, Eliza, et al.
Publicado: (2018)

Immunotargeting of Cancer Stem Cells
por: Köseer, Ayse Sedef, et al.
Publicado: (2023)

Immunotargeting in the management of psoriasis
por: Kaffenberger, Benjamin H, et al.
Publicado: (2013)

Hairy cell leukemia – immunotargets and therapies
por: Basheer, Faisal, et al.
Publicado: (2014)

Prion diseases: immunotargets and therapy
por: Burchell, Jennifer T, et al.
Publicado: (2016)

Immunotargets and Therapy for Prurigo Nodularis
por: Labib, Angelina, et al.
Publicado: (2022)

Designer Cytokine Hyper Interleukin 11 (H11) is a Megakaryopoietic Factor
por: Dams-Kozlowska, Hanna, et al.
Publicado: (2013)

Immunotargeting of collagenase on thrombus
por: Lu, Yi-ling, et al.
Publicado: (2010)

Tumor Immunotargeting Using Innovative Radionuclides
por: Kraeber-Bodéré, Françoise, et al.
Publicado: (2015)

A designer hyper interleukin 11 (H11) is a biologically active cytokine
por: Dams-Kozlowska, Hanna, et al.
Publicado: (2012)

Inhibition of tumor angiogenesis by globotriaosylceramide immunotargeting
por: Birklé, Stéphane, et al.
Publicado: (2013)

Trichoderma species occurring on wood with decay symptoms in mountain forests in Central Europe: genetic and enzymatic characterization
por: Błaszczyk, Lidia, et al.
Publicado: (2015)

CD146 is a potential immunotarget for neuroblastoma
por: Obu, Satoshi, et al.
Publicado: (2021)

Immunotargeting relapsed or refractory precursor B-cell acute lymphoblastic leukemia – role of blinatumomab
por: Queudeville, Manon, et al.
Publicado: (2017)

Programmed Death Ligand 1; An Immunotarget for Renal Cell Carcinoma
por: Chandrasekaran, Deepika, et al.
Publicado: (2019)

Effects of Designer Hyper-Interleukin 11 (H11) on Hematopoiesis in Myelosuppressed Mice
por: Dams-Kozlowska, Hanna, et al.
Publicado: (2016)

Nanobodies targeting ABCC3 for immunotargeted applications in glioblastoma
por: Ruiz-López, Eduardo, et al.
Publicado: (2022)

Novel monoclonal antibodies against thymidine kinase 1 and their potential use for the immunotargeting of lung, breast and colon cancer cells
por: Velazquez, Edwin J., et al.
Publicado: (2020)

Pre-Targeting and Direct Immunotargeting of Liposomal Drug Carriers to Ovarian Carcinoma
por: Lehtinen, Julia, et al.
Publicado: (2012)

Abnormal Innate Immunity in Acute-on-Chronic Liver Failure: Immunotargets for Therapeutics
por: Khanam, Arshi, et al.
Publicado: (2020)

Granulocyte-macrophage colony-stimulating factor: an immunotarget for sepsis and COVID-19
por: Mu, Xiuying, et al.
Publicado: (2021)

Immunotargeted therapy in melanoma: patient, provider preferences, and willingness to pay at an academic cancer center
por: Stenehjem, David D., et al.
Publicado: (2019)

Immunotargeting of tumor subpopulations in melanoma patients: A paradigm shift in therapy approaches
por: Maurer, Margarita, et al.
Publicado: (2012)

Combination of Bone-Modifying Agents with Immunotarget Therapy for Hepatocellular Carcinoma with Bone Metastases
por: Chen, Zhaoyu, et al.
Publicado: (2022)

In vivo measurement of the association constant of a radio-labelled monoclonal antibody in experimental immunotargeting.
por: Fjeld, J. G., et al.
Publicado: (1992)

Immune checkpoint inhibitors for patients with advanced lung cancer and oncogenic driver alterations: results from the IMMUNOTARGET registry
por: Mazieres, J., et al.
Publicado: (2019)

Bromodomain (BrD) Family Members as Regulators of Cancer Stemness—A Comprehensive Review
por: Czerwinska, Patrycja, et al.
Publicado: (2023)

The role of TRIM family proteins in the regulation of cancer stem cell self‐renewal
por: Jaworska, Anna Maria, et al.
Publicado: (2019)

PD-1/PD-L1 inhibitor activity in patients with gene-rearrangement positive non-small cell lung cancer—an IMMUNOTARGET case series
por: Mushtaq, Rao, et al.
Publicado: (2022)

Immunotargeting of tumor vasculature: preclinical development of novel antibody-based imaging and therapy against TEM1/CD248
por: Li, Chunsheng, et al.
Publicado: (2013)

Evaluation of Dimercaptosuccinic Acid-Coated Iron Nanoparticles Immunotargeted to Amyloid Beta as MRI Contrast Agents for the Diagnosis of Alzheimer’s Disease
por: Ulanova, Marina, et al.
Publicado: (2023)

Vascular Immunotargeting to Endothelial Determinant ICAM-1 Enables Optimal Partnering of Recombinant scFv-Thrombomodulin Fusion with Endogenous Cofactor
por: Greineder, Colin F., et al.
Publicado: (2013)

Programmed cell death 1 checkpoint inhibitors in the treatment of patients with advanced melanoma
por: Mackiewicz, Jacek, et al.
Publicado: (2017)

Immunotargeting of Integrin α(6)β(4) for Single-Photon Emission Computed Tomography and Near-Infrared Fluorescence Imaging in a Pancreatic Cancer Model
por: Aung, Winn, et al.
Publicado: (2016)

Therapeutic melanoma vaccine with cancer stem cell phenotype represses exhaustion and maintains antigen-specific T cell stemness by up-regulating BCL6
por: Czerwinska, Patrycja, et al.
Publicado: (2020)

Mining Transcriptomic Data to Uncover the Association between CBX Family Members and Cancer Stemness
por: Czerwinska, Patrycja, et al.
Publicado: (2022)

BRAF and MEK inhibitors in the era of immunotherapy in melanoma patients
por: Mackiewicz, Jacek, et al.
Publicado: (2018)

Secretory IgA in Intestinal Mucosal Secretions as an Adaptive Barrier against Microbial Cells
por: Pietrzak, Bernadeta, et al.
Publicado: (2020)

The influence of abiotic factors on the bloom-forming alga Ulva flexuosa (Ulvaceae, Chlorophyta): possibilities for the control of the green tides in freshwater ecosystems
por: Rybak, Andrzej Stanisław, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_ssnf8ku4fcu9qiov12lodiq6ol